- Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024
- Quanterix Releases Financial Results for the First Quarter of 2024
- Quanterix To Report First Quarter 2024 Financial Results
- Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
- Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
- Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023
- Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance
- Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease
More ▼
Key statistics
As of last trade, Quanterix Corp (QTRX:NMQ) traded at 16.34, 14.63% above the 52 week low of 14.26 set on May 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 16.56 |
---|---|
High | 16.71 |
Low | 16.31 |
Bid | 16.25 |
Offer | 16.31 |
Previous close | 16.56 |
Average volume | 286.59k |
---|---|
Shares outstanding | 38.27m |
Free float | 35.80m |
P/E (TTM) | -- |
Market cap | 633.75m USD |
EPS (TTM) | -0.9594 USD |
Data delayed at least 15 minutes, as of May 24 2024 16:35 BST.
More ▼